Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Mayne Pharma Group ( (AU:MYX) ).
Mitsubishi UFJ Financial Group, Inc. has increased its voting power in Mayne Pharma Group Limited, with a notable change in the number of fully paid ordinary shares held by the financial group. This adjustment in shareholding reflects a strategic move by Mitsubishi UFJ Financial Group, Inc. to strengthen its influence within Mayne Pharma Group Limited, potentially impacting the company’s governance and stakeholder dynamics.
The most recent analyst rating on (AU:MYX) stock is a Buy with a A$7.09 price target. To see the full list of analyst forecasts on Mayne Pharma Group stock, see the AU:MYX Stock Forecast page.
More about Mayne Pharma Group
Average Trading Volume: 980,618
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$429.8M
See more data about MYX stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue